Health Canada
Symbol of the Government of Canada
Drugs and Health Products

MSM

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section

Note: The archived version of this monograph has been temporarily removed. For an electronic copy of this archived version, please contact the Natural Health Products Directorate (NHPD) at NHPD_DPSN@hc-sc.gc.ca.


Date: June 26, 2008

Proper name(s): Methylsulfonylmethane, dimethyl sulfone, sulfonylbismethane (ChemIDplus 2008; O'Neil et al. 2001)

Common name(s): Methylsulfonylmethane (ChemIDplus 2008; O'Neil et al. 2001), MSM (ChemIDplus 2008)

Source material(s): Synthetic (O'Neil et al. 2001)

Route(s) of administration: Oral

Dosage form(s): Those suited to the allowable route(s) of administration
This monograph is not intended to include food-like dosage forms such as bars, chewing gums or beverages.

Use(s) or Purpose(s): Statement(s) to the effect of:

  • Helps to relieve joint pain associated with osteoarthritis (Kim et al. 2005; Usha and Naidu 2004).
  • Helps to relieve the pain associated with osteoarthritis of the knee (Kim et al. 2005; Usha and Naidu 2004).

Dose(s): 1,500-6,000 mg, per day (Kim et al. 2005; Usha and Naidu 2004)

Note: Products must not exceed 2,000 mg per dose.

Directions for use: Take with food. Avoid taking at bedtime (Kim et al. 2005).

Duration of use: Use for a minimum of 4 weeks to see beneficial effects (Kim et al. 2005; Usha and Naidu 2004).

Risk information: Statement(s) to the effect of:

Caution(s) and warning(s):

  • Consult a health care practitioner if symptoms worsen.
  • Consult a health care practitioner prior to use if you are pregnant or breastfeeding.

Contraindication(s): No statement required.

Known adverse reaction(s): Some people may experience mild gastrointestinal bloating, constipation or indigestion (Kim et al. 2005).

Non-medicinal ingredients: Must be chosen from the current NHPD List of Acceptable
Non-medicinal Ingredients and must meet the limitations outlined in the list.

Specifications:

  • The finished product must comply with the minimum specifications outlined in the current NHPD Compendium of Monographs.
  • The medicinal ingredient may comply with the specifications outlined in the Methylsulfonylmethane Monograph published in the United States Pharmacopoeia.

References cited:

ChemIDplus 2008: Methylsulfonylmethane. [online]. [Accessed 23 June 2008]. Available from: http://chem.sis.nlm.nih.gov/chemidplus/jsp/common/ChemFull.jsp?MW=94.1334

Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. 2006. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial. Osteoarthritis Cartilage 14:286-294.

O'Neil MJ, Smith A, Heckelman PE, Budavari S, editors. 2001. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 13th edition. Whitehouse Station (NJ): Merck & Co., Inc.

Usha PR, Naidu MUR. 2004. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clinical Drug Investigation 24(6):353-363.

References reviewed:

Altman R, Brandt K, Hochberg M, Moskowitz R, Bellamy N, Bloch DA, Buckwalter J, Dougados M, Ehrlich G, Lequesne M, Lohmander S, Murphy WA Jr, Rosario-Jansen T, Schwartz B, Trippel S. 1996. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society; Results from a workshop. Osteoarthritis Cartilage 4(4):217-43.

Horvath K, Noker PE, Somfai-Relle S, Glávits R, Financsek I, Schauss AG. 2002. Toxicity of methylsulfonylmethane in rats. Food and Chemical Toxicology 40:1459-1462.

Lin A, Nguy CH, Shic F, Ross BD. 2001. Accumulation of methylsulfonylmethane in the human brain: identification by multinuclear magnetic resonance spectroscopy. Toxicology Letters 123:169-177.

Magnuson BA, Appleton J, Ames GB. 2007. Pharmacokinetics and Distribution of [35S]Methylsulfonylmethane Following Oral Administration to Rats. Journal of Agriculture and Food Chemistry 55:1033-1038.

Marieb E. 1992. Human Anatomy and Physiology, 2nd edition. Redwood City (CA): The Benjamin/Cummings Publishing Company, Inc.